Wakefield, MA - 03/01/2023
Recelera, a privately held drug discovery firm developing solutions for Neurodegenerative diseases announces today that it has been acquired by a private investment group for a consideration of US$153m. The company will continue to be based in the Boston area and is looking to continue to build on its past successes.
Add a subtitle here.
© 2019